Person in Charge: Huang Shiang
Brief Introduction: Founded in 2005, the laboratory has integrated basic theoretical research, clinical application of diagnosis and treatment, and technological development. The laboratory focuses on the diagnosis and treatment of cancer and cardiovascular diseases, relies on four technology platforms of molecule, protein, cell and tissue for research of epigenetics and gene therapy, recombinant protein vaccine therapy, stem cell and cell therapy, tissue reconstruction and tissue repair, closely combines basic research with clinical diagnosis and treatment, and strivesto make breakthrough progress in the basic theory and technology application of biologically targeted therapy research for obtaining substantive achievements in the technology development and clinical application.
